Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tapiero

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Toxicology Letters|April 30, 1999
Apoptosis inhibition and ornithine decarboxylase superinduction as early epigenetic events in morphological transformation of Syrian hamster embryo cells exposed to 2-methoxyacetaldehyde, a metabolite of 2-methoxyethanolS Dhalluin, Z Elias, O Poirot, et al.
Anticancer Research|November 1, 1989
Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036H Tapiero, M B Yin, J Catalin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
An oriented phase II trial of THP-adriamycin in breast carcinomaG Mathé, H Umezawa, S Oka, et al.
Biochemistry|March 4, 1997
Circumvention of P-GP MDR as a function of anthracycline lipophilicity and chargeT J Lampidis, D Kolonias, T Podona, et al.
Cancer Research|August 1, 1990
3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaksN Horichi, H Tapiero, Y Sugimoto, et al.
Cancer Treatment Reports|June 1, 1984
Phase I-II study of aclarubicin for treatment of acute myeloid leukemiaD Machover, J Gastiaburu, M Delgado, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemiaD Machover, J Gastiaburu, M Delgado, et al.
International Journal of Cancer|March 12, 1998
Two-stage exposure of Syrian-hamster-embryo cells to environmental carcinogens: superinduction of ornithine decarboxylase correlates with increase of morphological-transformation frequencyS Dhalluin, Z Elias, V Cruciani, et al.
Biochemical Pharmacology|December 1, 1989
Relevance of the chemical charge of rhodamine dyes to multiple drug resistanceT J Lampidis, C Castello, A del Giglio, et al.
European Journal of Haematology. Supplementum|January 1, 1987
Phase I-II study of aclarubicin for treatment of acute myeloid leukaemiaD Machover, J Gastiaburu, M Delgado, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Toxicology Letters|April 30, 1999
Apoptosis inhibition and ornithine decarboxylase superinduction as early epigenetic events in morphological transformation of Syrian hamster embryo cells exposed to 2-methoxyacetaldehyde, a metabolite of 2-methoxyethanolS Dhalluin, Z Elias, O Poirot, et al.
Anticancer Research|November 1, 1989
Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036H Tapiero, M B Yin, J Catalin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
An oriented phase II trial of THP-adriamycin in breast carcinomaG Mathé, H Umezawa, S Oka, et al.
Biochemistry|March 4, 1997
Circumvention of P-GP MDR as a function of anthracycline lipophilicity and chargeT J Lampidis, D Kolonias, T Podona, et al.
Cancer Research|August 1, 1990
3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaksN Horichi, H Tapiero, Y Sugimoto, et al.
Cancer Treatment Reports|June 1, 1984
Phase I-II study of aclarubicin for treatment of acute myeloid leukemiaD Machover, J Gastiaburu, M Delgado, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemiaD Machover, J Gastiaburu, M Delgado, et al.
International Journal of Cancer|March 12, 1998
Two-stage exposure of Syrian-hamster-embryo cells to environmental carcinogens: superinduction of ornithine decarboxylase correlates with increase of morphological-transformation frequencyS Dhalluin, Z Elias, V Cruciani, et al.
Biochemical Pharmacology|December 1, 1989
Relevance of the chemical charge of rhodamine dyes to multiple drug resistanceT J Lampidis, C Castello, A del Giglio, et al.
European Journal of Haematology. Supplementum|January 1, 1987
Phase I-II study of aclarubicin for treatment of acute myeloid leukaemiaD Machover, J Gastiaburu, M Delgado, et al.
Pageof 9